BR112017014116A2 - pcr quantitativo multiplex - Google Patents

pcr quantitativo multiplex

Info

Publication number
BR112017014116A2
BR112017014116A2 BR112017014116A BR112017014116A BR112017014116A2 BR 112017014116 A2 BR112017014116 A2 BR 112017014116A2 BR 112017014116 A BR112017014116 A BR 112017014116A BR 112017014116 A BR112017014116 A BR 112017014116A BR 112017014116 A2 BR112017014116 A2 BR 112017014116A2
Authority
BR
Brazil
Prior art keywords
target nucleic
nucleic acid
average
compositions
abundance
Prior art date
Application number
BR112017014116A
Other languages
English (en)
Inventor
Harley Calvin
Lin Jue
Guegler Karl
Original Assignee
Telomere Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Telomere Diagnostics Inc filed Critical Telomere Diagnostics Inc
Publication of BR112017014116A2 publication Critical patent/BR112017014116A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6851—Quantitative amplification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

são descritos métodos e composições para determinar o comprimento ou a abundância média de um primeiro nucleico alvo calculando-se a abundância de um primeiro ácido nucleico alvo (t) em relação à abundância média (s) de um segundo e um terceiro ácido nucleico alvo, em um único poço, utilizando-se uma etiqueta de detecção separada para cada ácido nucleico alvo. em vários aspectos, o primeiro ácido nucleico alvo é um telômero. em aspectos exemplificativos, os métodos e composições divulgados podem ser utilizados para determinar o comprimento médio de telômero em uma amostra biológica. o comprimento médio de telômero determinado utilizando os métodos e composições divulgados pode ser correlacionado com uma variedade de condições e índices clinicamente importantes. este resumo é concebido como uma ferramenta de verificação para fins de pesquisa na técnica específica e não é destinado a ser um fator limitante da presente invenção.
BR112017014116A 2014-12-30 2015-06-22 pcr quantitativo multiplex BR112017014116A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462098057P 2014-12-30 2014-12-30
US201562163434P 2015-05-19 2015-05-19
PCT/US2015/036991 WO2016108954A1 (en) 2014-12-30 2015-06-22 Multiplex quantitative pcr

Publications (1)

Publication Number Publication Date
BR112017014116A2 true BR112017014116A2 (pt) 2018-03-06

Family

ID=56163505

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017014116A BR112017014116A2 (pt) 2014-12-30 2015-06-22 pcr quantitativo multiplex

Country Status (9)

Country Link
US (2) US9944978B2 (pt)
EP (1) EP3240910B1 (pt)
JP (1) JP2018501799A (pt)
CN (1) CN107208145A (pt)
AU (1) AU2015372584A1 (pt)
BR (1) BR112017014116A2 (pt)
CA (1) CA2971169A1 (pt)
MX (1) MX2017008553A (pt)
WO (1) WO2016108954A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585974B1 (en) 2003-01-24 2013-02-27 University of Utah Methods of predicting mortality risk by determining telomere length
CN107083444B (zh) 2008-12-22 2023-03-14 犹他大学研究基金会 单色多重定量pcr
ES2762860T3 (es) 2013-05-22 2020-05-26 Telomere Diagnostics Inc Medidas de abundancia de telómeros cortos
US10580077B1 (en) * 2015-03-02 2020-03-03 Longevity Quest, Inc. System and method for providing a lifespan expectation to an insurance applicant
CN107022607B (zh) * 2017-03-16 2019-01-22 北京博奥晶典生物技术有限公司 通过碱基错配解决多重pcr时等位基因扩增不平衡的方法
EP3728645A4 (en) * 2017-12-22 2021-09-08 Gutfeeling Labs AB HEALTH STATE ANALYSIS PROCESS
CA3088250A1 (en) * 2018-01-22 2019-07-25 Luminex Corporation Methods and compositions for discrete melt analysis
CN112029841B (zh) 2019-06-03 2024-02-09 香港中文大学 定量端粒长度和基因组基序的方法
CN111041073B (zh) * 2019-12-31 2023-04-11 南昌五元生物科技有限公司 一种端粒长度的高通量检测方法
CN111705114B (zh) * 2020-06-11 2023-08-15 湖南圣洲生物科技有限公司 基于实时数字pcr检测人端粒绝对长度的方法及试剂盒
CN111996242A (zh) * 2020-08-21 2020-11-27 山东端泉健康科技有限公司 精子端粒长度测量试剂盒与应用

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS608745B2 (ja) 1978-02-14 1985-03-05 三洋化成工業株式会社 免疫活性物質−つや消しガラス複合体，その製造法及び該複合体を含有してなる測定試薬
US4469863A (en) 1980-11-12 1984-09-04 Ts O Paul O P Nonionic nucleic acid alkyl and aryl phosphonates and processes for manufacture and use thereof
EP0155747A1 (en) 1984-03-19 1985-09-25 Kidde, Inc. Tube culture system
US5034506A (en) 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US5235033A (en) 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5216141A (en) 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
US5386023A (en) 1990-07-27 1995-01-31 Isis Pharmaceuticals Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling
US5602240A (en) 1990-07-27 1997-02-11 Ciba Geigy Ag. Backbone modified oligonucleotide analogs
US5644048A (en) 1992-01-10 1997-07-01 Isis Pharmaceuticals, Inc. Process for preparing phosphorothioate oligonucleotides
US6020124A (en) 1992-04-27 2000-02-01 Trustees Of Dartmouth College Detection of soluble gene sequences in biological fluids
US5489508A (en) 1992-05-13 1996-02-06 University Of Texas System Board Of Regents Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
US6235470B1 (en) 1993-11-12 2001-05-22 The Johns Hopkins University School Of Medicine Detection of neoplasia by analysis of saliva
US5637684A (en) 1994-02-23 1997-06-10 Isis Pharmaceuticals, Inc. Phosphoramidate and phosphorothioamidate oligomeric compounds
US5512441A (en) 1994-11-15 1996-04-30 American Health Foundation Quantative method for early detection of mutant alleles and diagnostic kits for carrying out the method
US5741677A (en) 1995-06-07 1998-04-21 Geron Corporation Methods for measuring telomere length
US5856096A (en) 1995-09-20 1999-01-05 Ctrc Research Foundation Rapid and sensitive assays for detecting and distinguishing between processive and non-processive telomerase activities
AU7394696A (en) 1995-10-02 1997-04-28 Analyte Diagnostics, Inc. Sample collection, recovery and dispensing device for saliva
WO1997014026A2 (en) 1995-10-12 1997-04-17 Dako A/S Method for detecting multiple copies of a repeat sequence in a nucleic acid molecule
IN182876B (pt) 1995-11-22 1999-07-31 Abion Ohg
JP3718892B2 (ja) 1996-02-05 2005-11-24 三菱化学株式会社 ヒト・テロメラーゼ活性の測定方法
US5928916A (en) 1996-04-25 1999-07-27 Medtronic, Inc. Ionic attachment of biomolecules with a guanidino moiety to medical device surfaces
US5945319A (en) 1996-04-25 1999-08-31 Medtronic, Inc. Periodate oxidative method for attachment of biomolecules to medical device surfaces
US5910122A (en) 1996-06-04 1999-06-08 Americare Health Scan Inc. Saliva collector with an aspirating pipette
JP4013333B2 (ja) 1998-06-05 2007-11-28 株式会社Ｂ＆Ｃラボラトリーズ 皮膚の老化度の測定方法および測定用キット
US6022326A (en) 1998-10-30 2000-02-08 Lifepoint, Inc. Device and method for automatic collection of whole saliva
ATE317297T1 (de) 1998-11-23 2006-02-15 Us Gov Sec Army Reinigungsmethode und vorrichtung
EP1110984B1 (en) 1999-03-17 2005-08-17 Asahi Glass Company Ltd. Polyurethane / polyurethane-urea resin and process for producing the same
US6436677B1 (en) 2000-03-02 2002-08-20 Promega Corporation Method of reverse transcription
AU2001250803A1 (en) 2000-03-07 2001-09-17 E.I. Du Pont De Nemours And Company Real time quantitative pcr with intercalating dye for single and multiplex target dna
CA2450580A1 (en) 2001-06-23 2003-01-03 University Of Wales College Of Medicine Method for the determination of telomere length
US20030162209A1 (en) 2001-12-19 2003-08-28 George Martin PCR based high throughput polypeptide screening
CN100473723C (zh) 2002-01-31 2009-04-01 犹他州大学 扩增重复核酸序列
US20100311954A1 (en) 2002-03-01 2010-12-09 Xencor, Inc. Optimized Proteins that Target Ep-CAM
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
GB2391813B (en) 2002-08-14 2006-03-29 Cozart Bioscience Ltd An oral fluid collection, transfer and transportation device and method
BR0314751A (pt) 2002-09-27 2005-07-26 Powderject Res Ltd Partìculas adequadas para suprimento a partir de um dispositivo de suprimento, receptáculo de dosagem para um dispositivo de suprimento, dispositivo de suprimento mediado por partìcula, processo para a preparação de partìculas adequadas para suprimento a partir de um dispositivo de suprimento, e, métodos de imunização por ácido nucleico e de terapia genética
EP1594975A4 (en) 2002-12-04 2006-08-02 Applera Corp MULTIPLEX AMPLIFICATION OF POLYNUCLEOTIDES
EP1585974B1 (en) 2003-01-24 2013-02-27 University of Utah Methods of predicting mortality risk by determining telomere length
US20050009097A1 (en) 2003-03-31 2005-01-13 Better Marc D. Human engineered antibodies to Ep-CAM
JP4228041B2 (ja) 2003-07-08 2009-02-25 東洋紡績株式会社 塩基多型の検出方法
US20050180979A1 (en) 2004-02-13 2005-08-18 Micromet Ag Anti-EpCAM immunoglobulins
US20060141492A1 (en) 2004-07-27 2006-06-29 Sowers Kevin R Gene probes for the selective detection of microorganisms that reductively dechlorinate polychlorinated biphenyl compounds
US20080182252A1 (en) 2005-04-08 2008-07-31 Linkage Biosciences, Inc. Genotyping Hla Loci
US7998938B2 (en) 2005-04-15 2011-08-16 Geron Corporation Cancer treatment by combined inhibition of proteasome and telomerase activities
AU2006268227A1 (en) 2005-07-08 2007-01-18 Xencor, Inc Optimized anti-Ep-CAM antibodies
US20070059716A1 (en) 2005-09-15 2007-03-15 Ulysses Balis Methods for detecting fetal abnormality
MX2008007253A (es) 2005-12-09 2008-09-30 Dna Genotek Inc Sistema de contenedor para almacenar de forma liberable una sustancia.
US20070161031A1 (en) 2005-12-16 2007-07-12 The Board Of Trustees Of The Leland Stanford Junior University Functional arrays for high throughput characterization of gene expression regulatory elements
WO2008143679A2 (en) 2006-06-01 2008-11-27 Verenium Corporation Nucleic acids and proteins and methods for making and using them
US20080063628A1 (en) 2006-09-11 2008-03-13 Davis Janet E Methods to promote cell differentiation
US8318911B2 (en) 2007-04-04 2012-11-27 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Anti-EpCAM antibody and uses thereof
US20090142408A1 (en) 2007-07-23 2009-06-04 Telomolecular Corporation Telomerase delivery by biodegradable Nanoparticle
US20110244462A1 (en) 2007-08-10 2011-10-06 Tina Holding Aps Method for Estimating Telomere Length
CN201188066Y (zh) 2008-02-03 2009-01-28 上海邃志生物科技有限公司 一种能储存试剂的唾液采集装置
ES2633313T3 (es) 2008-08-21 2017-09-20 Dna Genotek Inc. Dispositivo de recepción de muestras
WO2010026913A1 (ja) 2008-09-08 2010-03-11 アークレイ株式会社 試料採取用具
US8658366B2 (en) * 2008-09-18 2014-02-25 Roche Molecular Systems, Inc. Detection of target variants using a fluorescent label and a soluble quencher
CN107083444B (zh) * 2008-12-22 2023-03-14 犹他大学研究基金会 单色多重定量pcr
US8039215B2 (en) 2009-03-10 2011-10-18 Roche Molecular Systems, Inc. Multiplex quantitative nucleic acid amplification and melting assay
US20110182862A1 (en) 2009-04-03 2011-07-28 Green Wayne A Endophytic fungus and uses therefor
EP2280080A1 (en) * 2009-07-31 2011-02-02 Qiagen GmbH Method of normalized quantification of nucleic acids using anchor oligonucleotides and adapter oligonucleotides
US20110207128A1 (en) 2010-02-16 2011-08-25 Cawthon Richard M Methods and kits for determining biological age and longevity based on gene expression profiles
WO2011103343A2 (en) 2010-02-17 2011-08-25 Biotime Inc. Methods for telomere length and genomic dna quality control analysis in pluripotent stem cells
US9624542B2 (en) * 2011-03-28 2017-04-18 Geron Corporation Telomere length measurement in formalin-fixed, paraffin embedded (FFPE) samples by quantitative PCR
WO2013054666A1 (ja) * 2011-10-13 2013-04-18 学校法人 東京女子医科大学 テロメア配列増幅用プライマー
WO2013102116A1 (en) 2011-12-31 2013-07-04 Telome Health, Inc. Saliva-derived measures of telomere abundance and sample collection device
CN103804867A (zh) 2012-11-15 2014-05-21 大连捌伍捌创新工场科技服务有限公司 一种复合纤维片材的制备方法
US10093970B2 (en) * 2013-03-15 2018-10-09 New York University Method for single cell analysis of telomere length using pre-amplification and multiple-copy reference sequence
ES2762860T3 (es) * 2013-05-22 2020-05-26 Telomere Diagnostics Inc Medidas de abundancia de telómeros cortos
JP2015175632A (ja) 2014-03-13 2015-10-05 株式会社デンソー 力学量センサ

Also Published As

Publication number Publication date
MX2017008553A (es) 2018-03-14
CA2971169A1 (en) 2016-07-07
EP3240910A4 (en) 2018-06-06
WO2016108954A1 (en) 2016-07-07
US20160186250A1 (en) 2016-06-30
US9944978B2 (en) 2018-04-17
US20180237843A1 (en) 2018-08-23
CN107208145A (zh) 2017-09-26
AU2015372584A1 (en) 2017-06-29
EP3240910A1 (en) 2017-11-08
EP3240910B1 (en) 2020-11-18
JP2018501799A (ja) 2018-01-25

Similar Documents

Publication Publication Date Title
BR112017014116A2 (pt) pcr quantitativo multiplex
BR112018075479A2 (pt) portadores híbridos para carga de ácido nucleico
WO2015123430A3 (en) Single molecule electronic multiplex snp assay and pcr analysis
EP4303314A3 (en) Polypeptide tagged nucleotides and use thereof in nucleic acid sequencing by nanopore detection
BR112017008082A2 (pt) composições e métodos para detectar um vírus de rna
BR112017017025A2 (pt) métodos e composições para analizar componentes celulares
DK3530752T3 (da) Rumligt adskilt, multipleks nukleinsyreanalyse af biologiske prøver
BR112018003631A2 (pt) sistemas e métodos para busca por variante de alta precisão
BR112016019267B8 (pt) Método para construir um perfil de dna, biblioteca de ácido nucléico, método para construir uma biblioteca de ácido nucléico, pluralidade de iniciadores e kit
WO2014116729A3 (en) Haplotying of hla loci with ultra-deep shotgun sequencing
BR112016029521A2 (pt) ?kit, dispositivo e método para a detecção de câncer de estômago?
BR112018013430A2 (pt) ?métodos para detectar pelo menos uma mutação em uma pluralidade de genes relacionados a câncer de tireoide, para selecionar um sujeito que tem nódulos na tireoide e para prognosticar risco de malignidade, e, kit?
BR112014015152A2 (pt) métodos e materiais para a avaliação da perda de heterozigosidade
GB2526736A (en) Methods, compositions, and kits for nucleic acid analysis
BR112014007214A2 (pt) predição de evento de risco cardiovascular e utilização do mesmo
GB201317477D0 (en) Methods, compositions and kits for determing the presence/absnece of a variant nucleic acid sequence
MY190837A (en) Polymethine compounds and their use as fluorescent labels
BR112016028442A2 (pt) processos para detectar a metilação de citosina de ácido nucleico alvo de interesse e/ou diagnosticar ou monitorar estado de saúde em paciente e kit
BR112016028534A2 (pt) ceramidas e seu uso em diagnosticar cvd
WO2016100438A3 (en) Polymerase compositions and methods of making and using same
BR112017023473A2 (pt) método de detecção e quantificação de ácido nucleico e composições
BR112014014307A2 (pt) métodos e kits para detecção in situ à temperatura ambiente de um ácido nucleico alvo em uma amostra biológica
BR112017023726A2 (pt) detecção de fatores de virulência microbiana na cavidade oral
BR112017014878A2 (pt) métodos para manter a precisão na medição de um parâmetro de água industrial e de uma pluralidade de parâmetros de água industrial.
AR097489A1 (es) Marcadores de riesgo para cardiovasculopatías en pacientes con nefropatía crónica

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2728 DE 18/04/2023.